) of approximately 0.05 mg/kg. Taken together, these findings establish Lipid-392 stLNP as a safe, efficient, and versatile platform for lung-targeted RNA delivery with broad therapeutic potential for various diseases and promising translational applications.
Fei et al. (2026) studied this question.